美股异动 | 黑莓大升14% Q4每股亏损低于市场预期
格隆汇3月31日丨黑莓升14.75%,报4.59美元,总市值27亿美元。黑莓2023年Q4财报实现营收1.51亿美元,前值为1.85亿美元,预期值为1.567亿美元,比市场预期低3.61%;每股亏损0.02美元,前值为0.01美元,预期值为亏损0.07美元,低于市场预期71.43%。此外,黑莓宣布,已达成协议,将其非核心专利和专利申请出售给Key Patent Innovations Limited(KPI)新成立的子公司Malikie Innovations Limited(Malikie),交易产生的现金收益及潜在的未来特许权使用费总额高达9亿美元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.